CME Group Cl A shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

CME Group posts strong earnings on growing trading volumes and margins. Learn the risks, market opportunities, and why it's ...

CME Group is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key ...

What Happened: In a significant move reported in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, Suskind purchased 532 shares of CME Group, demonstrating confidence in ...

Price to Sales (P/S) Ratio: The current P/S ratio of 15.63 is above industry norms, reflecting an elevated valuation for CME Group's stock and potential overvaluation based on sales performance.

Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization. CME Group: Financial Performance Dissected ...

CME Group Inc.’s share was trading at $273.99 as of June 20th. CME’s trailing and forward P/E ratios were 27.56 and 24.88, respectively, according to Yahoo Finance.

CME Group Inc. (CME), headquartered in Chicago, Illinois, operates contract markets for the trading of futures and options on ...

KKR shares have fallen 9% year-to-date, underperforming the alternative asset manager group, which is down 2%, and the S&P ...